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Introduction
Oral squamous cell carcinoma is the 5 th leading cause of death in Canada [1] and the overall high mortality rate (average 57% survival in 5 years) has changed minimally over the previous 10 year period. A total of 42,440 new cases and 8, 390 deaths are estimated in the United States in 2014 [2] . The high mortality rate of patients with oral cancer is associated with its late detection and subsequent increase in the occurrence metastatic disease. The 5-year survival rate for oral cancer drops from approximately 60% to 30% for patients with metastatic disease [1] . Recent advances have been made in understanding the genetic changes and molecular mechanisms regulating OSCC progression, including the role of neutrophils in this process.
Neutrophils are key mediators of the innate immune system. Neutrophil activation is essential to protect the host system against infections and promote normal healing [3] . For many decades, leukocytosis has been associated with a poor prognosis in different types of malignancies [4] . Despite this, the specific role of neutrophils and macrophages in the pathogenesis of cancer has only recently become the subject of intense research [5, 6] with special focus on the association between inflammation and cancer progression. This idea was initiated by Pekarek et al. who showed that neutrophils can induce tumor angiogenesis [7] , prompting a significant number of research groups to investigate possible neutrophil pro-tumor or anti-tumor roles as well as their potential uses as diagnostic and prognostic markers. Recent work has shown that neutrophils are important players in cancer biology [8, 9] and different neutrophil sub-populations may have opposing roles in cancer progression where an N1 population was demonstrated to have anti-tumor properties and an N2 population of neutrophils was shown to promote tumor progression. The N1 phenotype is induced by INFb and is characterized by reduced MMP9 expression, increased reactive oxygen species (ROS) formation, and apoptosis [10] . The N2 neutrophils develop a pro-tumor phenotype after TGFb stimulation, leading to increased Arginase, MMP9 and collagenase expression, AKT activation, and promotion of leukocyte recruitment [9] . This N2 phenotype is particularly relevant for OSCC patients, since OSCC show increased expression of IL1b, IL-6 and TGFb [11] . These proposed opposing roles for neutrophils suggest that they may be important biomarkers for OSCC and perhaps targets to control cancer progression [12] .
During the past 4 years, an increasing number of publications have shown that neutrophils are present in a variety of tumors, including renal cell carcinomas and head and neck carcinomas [13] and that they may contribute to tumor progression [14, 15] , metastasis [16] , and extracellular traps (NET)-dependent tumor metastasis [17] . The general roles of neutrophils in cancer pathogenesis and prognosis have been reviewed elsewhere [6, 12] , but the particular roles of neutrophils in the diagnosis, prognosis and progression of oral squamous cell carcinomas have not yet been reviewed. Considering the constant presence of neutrophils in the oral tissues due to the oral biofilms, there is an increased interest in analyzing how the presence of neutrophils modulates OSCC behavior. The literature on OSCC and neutrophils is limited compared to other cancers and we added publications on head and neck squamous cell carcinomas (HNSCC) to this discussion.
In the next sections, we will analyze our current knowledge about the roles of neutrophils in the progression of oral squamous cell carcinoma in three main categories: biomarkers, microenvironment changes, and intercellular signaling ( Figure 1 ). immunostaining correlated with poor patient survival [13] . These findings were consistent with a recent report by Wang et al. who showed that tongue squamous cell carcinomas with high neutrophil infiltration displayed increased lymph node metastasis, higher clinical stage and increased chances of tumor recurrence [18] .
Neutrophils as biomarkers of OSCC

Neutrophil-to-lymphocyte ratio (NLR)
The neutrophil-to-lymphocyte ratio (NLR) is a well established marker of poor prognosis in various conditions including cardiovascular diseases [19] and cancers [20, 21] including head and neck carcinomas [22] . An increase in NLR is indicative of an ongoing inflammatory state with decrease in regulatory pathways.
Millrud and coworkers have correlated the activation pattern of leukocytes and survival of HNSCC patients [23] where the prognostic markers (CD71, CD98, CD4/8 ratio, CD16/14) and a high NLR correlated with poor prognosis. Perisanidis et al. evaluated 97 patients with biopsy proven OSCC who received neoadjuvant chemotherapy and showed that a high NLR (>1.9) is an independent marker for poor prognosis in OSCC patients [24] . Although this finding suggests that the NLR may be an important OSCC prognostic biomarker, larger prospective studies are needed to further clarify the use of NLR, the mechanisms and relevance behind the changes in lymphocyte and neutrophil counts in OSCC.
Neutrophil-secreted proteins
Numerous studies have used neutrophil-secreted products as diagnostic and prognostic markers of cancer. Among these, human defensins (HNP), TNF family proteins and neutrophil gelatinase associated lipocalin (NGAL) have been studied in the OSCC patients.
Human defensins (HNP1, HNP2 and HNP3) are known to induce cytotoxic effects in numerous target cells, including SCC cells [25] . In a search for a possible This finding also correlated with an increase in neutrophil infiltrates [26] . HNPs were also elevated in the saliva of OSCC patients but the clinical significance of this finding has yet to be clarified [27] [28] [29] .
Members of the TNF superfamily of secreted proteins, including APRIL [30] , TRAIL and DR5 [31] were also investigated as possible oral cancer biomarkers. The proliferation-induced ligand APRIL has been shown to regulate tumor cell survival and proliferation through binding to heparin sulfate side chains of proteoglycans (HSPG) or to the calcium modulator and cyclophilin ligand interactor (TACI) [32] . Jablonska et al. analyzed the expression of APRIL in peripheral blood neutrophils of patients with OSCC and found a correlation between high expression and poor prognosis. TRAIL is a soluble TNFa family ligand produced by numerous cells and may be a promising candidate to promote cancer suppression. TRAIL induces apoptosis by activation of DR receptors, including DR1 and DR5, and its expression and release are decreased in late stage squamous cell carcinoma [31] . Since many cells in the tumor microenvironment may secrete TRAIL, further studies are needed to better understand the role and the prognostic importance of neutrophil-derived TRAIL in OSCC progression.
Neutrophil gelatinase associated lipocalin (NGAL) is a regulator of iron and hydrophobic-compounds transport, and has an important role in protecting MMP9 from degradation. Recent studies have described a pro-tumor role for NGAL in different tumors, including breast and esophageal cancers [33] . NGAL has also been shown to be up-regulated in well differentiated OSCC while poorly differentiated tumors showed a weak expression, suggesting a possible role for this protein in tumor staging [34] .
Reactive oxygen species
Reactive oxygen species have an increasing number of roles in different cellular processes, including phagocyte killing, chemotaxis, apoptosis, and intracellular signaling [35] . The formation of ROS by neutrophils is decreased in most cancers [9] . Peripheral blood neutrophils from patients with head and neck squamous cell carcinoma had lower ROS production [36] and reduced apoptosis [13] . This mechanism is dependent on the p38 MAPK pathway. Similarly, Jablonska and others showed that iNOS expression and NO production are significantly reduced in peripheral blood neutrophils of OSCC patients [37] . Although ROS are not considered biomarkers of cancer progression, future studies will clarify the signaling changes in TANs and the reduction of ROS in these cells. This may contribute to the understanding of the crosstalk between cancer cells and TANs.
Neutrophils remodeling the cancer microenvironment
One of the most interesting recent findings suggests that neutrophils are recruited to the niches of distant cancer metastasis, and may be a key player in the establishment of metastatic spread [16] . Similarly, Huh et al. found that neutrophils were recruited and increased the metastatic spread of melanoma through an IL-8 dependent mechanism [38] .
Matrix Metaloproteases
The cancer microenvironment is a complex niche that is constantly being remodelled by fibroblasts, inflammatory and cancer cells. Neutrophils secrete MMP8 (collagenase), MMP9 (gelatinase), elastase, cathepsin G, proteinase 3 and other matrix proteases that contribute to the remodelling of the tumor microenvironment. These proteases can degrade the extracellular matrix directly and facilitate the invasion of cancer cells [39] , or alternatively activate MT1MMP in the tumor cells and indirectly facilitate cancer progression [40] . Moilanen et al. showed that MMP8 is also secreted by head and neck squamous cell carcinomas, including oral cancers [41] . MMP9 is also known to regulate tumor angiogenesis, a key factor in tumour progression (see below). In tumors where macrophages are the main source of MMP9, inhibition of macrophage recruitment induces a compensatory response, increasing the recruitment of MMP9+ neutrophils which have a pro tumor phenotype [42] . Further studies are needed to verify the significance of this mechanism in OSCC.
Angiogenesis
Neutrophils are known to promote tumor angiogensis through upregulation of MMP9 and VEGF [43] . Bausch and others have shown that MMP9 is a VEGFindependent angiogenic factor with an additive effect to VEGF-induced angionenenis in hepatocellular carcinoma. Complete inhibition of angiogenesis requires both MMP9 and VEGF inhibition [44] Unlike other cells, neutrophils secrete proMMP9 without the inhibitor TIMP1, providing a readily active MMP9, which is critical for tumor angiogenesis and 
Neutrophil extracellular traps (NET) and adhesion molecules
Recent evidence shows that neutrophils may also contribute to the metastatic spread of cancers by facilitating the seeding of circulating cancer cells [46] . Several mechanisms have been described to explain the neutrophil-mediated metastatic spread, including NETs. NETs are composed of extruded neutrophilic DNA that can be seen under normal systemic inflammatory/infectious responses.
Cools-Lartigue et al. have showed that NETs sequester circulating cancer cells and
increase the formation of liver micrometastasis [17] . There are no publications describing the role of NETs in OSCC metastasis. Further studies are needed to understand the clinical relevance of this mechanism in OSCC .
Modulation of cell function and signaling
Both neutrophils and cancer cells influence the behaviour of each other in the cancer microenvironment [39, 47] . Recent key studies have identified potential pathways involved in the crosstalk between cancer cells and neutrophils. We will focus this discussion on the regulation of cell function and signaling between OSCC and neutrophils.
Dumitru and co-workers recently showed that tumor associated neutrophils increased cortactin phosphorylation in oropharyngeal squamous cell carcinomas, promoting cancer migration, leading to a poor prognosis [48] . This is a promising result that links the presence of TAN with cytoskeletal changes in the cancer cells.
More importantly, cortactin is an essential actin binding protein, regulating leading edge formation and invadopodia formation in cancer cells [49] .
Trellakis and coworkers performed a functional analysis of peripheral blood neutrophils to show that the peripheral blood of HNSCC patients had an increase in PMN, CXCL8, CCL4 and CCL5 [13] . In vitro analysis showed an increased migration and increased survival of PMN exposed to FaDu cells or FaDu cells supernatant (SN). Neutrophils show increased survival when exposed to supernatants from different tumors, including squamous cell carcinoma, as shown by different groups [51] . Several mechanisms are implicated in the prolonged survival of neutrophils, including the release of cytokines and hyaluronan by tumor cells and other cells in the microenvironment [52, 53] . The macrophage migration inhibitory factor (MIF) was recently shown to modulate the activation and increase survival of neutrophils [53] . MIF significantly increased neutrophil chemotaxis, reduced apoptosis, and increased the expression of CCL4 and MMP9 through a CXCR2-dependent mechanism. Samples from cancer patients were also used to show that MIF expression in tumors correlate with neutrophil recruitment and poor survival. The observation that neutrophils survive longer in the tumor microenvironment challenges the initial understanding that neutrophils, as extremely short-lived cells, could not participate effectively in tumor progression that occurs over an extended period of time. Also, increased neutrophil survival translates into sustained inflammation and secretion of neutrophil inflammatory mediators that may contribute to tumor progression.
Concluding remarks
Increasing roles of innate immune cells in cancer biology
Considering the increased interest in the development of targeted therapies, immune cells have become a primary target for prognosis and possible treatment of cancers and this is valid for almost all malignancies, including OSCC. The dogma of the short-lived, "non-specific" neutrophil in cancer is disappearing and is being replaced by the concept of the neutrophil as a protagonist in cancer progression.
There are many reasons that support this hypothesis. First, the neutrophil has extremely efficient motility machinery, allowing it to be recruited quickly to 
Neutrophils, cancer and the oral microenvironment
Considering the oral microenvironment, the constant presence of neutrophils in the saliva may be an important factor in early malignant transformation, signaling and, most importantly, a marker for disease progression that is easily accessible with a mouth rinse, without the need of blood collection [54, 55] . Also, there are numerous conditions that are characterized by changes in the neutrophil population in the mouth, including periodontal disease [55, 56] . These changes in neutrophils may be involved in the observed increase in the rate of oral epithelial malignant transformation in chronic inflammatory states [57, 58] . Certainly, more research is needed to address these topics. Another important question is whether the modulation of neutrophil activity can influence the development or prognosis of oral cancers. There is evidence to suggest that maintaining good oral hygiene and therefore low neutrophil counts in the saliva correlate with small prevalence of oral cancer [59, 60] . Finally, the accessible oral microenvironment could also be a potential candidate for local treatments for early OSCC.
Future directions
There are still many unanswered questions regarding the role of neutrophils in cancer pathogenesis in general. The literature on oral squamous cell carcinoma and neutrophils is limited compared to other models. New exciting results show tat neutrophils inhibit seeding in the premetastastic lung in a breast cancer model [61] and recruit T regulatory cells that may contribute to a decreased antitumor response [62] . Further studies analyzing the role of these mechanisms in OSCC are needed.
The most challenging topic to be addressed in the next few years is how to modulate neutrophil activity to increase tumor surveillance and early suppression.
Identifying the signaling switches is essential to developing treatments to precisely target this interaction. Also, considering the particularities of OSCC, how can we develop localized treatment strategies? Since oral neutrophils are readily available, research is needed to evaluate the genetic signature changes of neutrophils exposed to OSCC.
The most promising area of research is the development of a sensitive and specific diagnostic/prognostic marker for OSCC, which may be associated with saliva tests. Analyzing neutrophils from OSCC patients' saliva might prove to be a good prognostic marker.
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